KD Pharma ’s unique technology mix produces Omega-3 concentrates of the highest quality and purity, while producing a wide range of Omega-3 EPA and DHA fatty acids.
EPA fatty acids can be concentrated up to 99 % and DHA up to 95%. In addition, our technology allows for the production of specialty products like the KD-PÜRSDA300EE-PLUS. The production process for all products is completed under GMP conditions.
API’s are available in scalable quantities. All products can be produced as an ethyl ester, triglyceride or free fatty acid with the standard package size for all products being 190 kg drums that are flushed with inert gas. The tables below outline our standard product formulations. Additionally, KD Pharma is capable of developing a variety of customized compositions according to your needs.
KD Pharma's Approved Pharmaceutical Ingredients (APIs, mg/g)
KD-Pür® (mg/g) Pharmaceuticals
|PRODUCT||EPA||DHA||EPA + DHA||OMEGA-3 FATTY ACIDS|
|460380EE (EP) Generic Omacor||430-495||347-403||800-882||NLT 90%|
|465375EE (USP) Generic Lovaza||430-495||347-403||800-880||NLT 90%|
|46037EE (JP) Generic Lotriga||430-495||347-403||800-880||NLT 90%|
|EPA96% (JP) Generic Epadel||96.5%-101.0%||not defined||not defined||not defined|
EP - European Pharmacopeia, USP - US Pharmacopeia, JP - Japanese Pharmacopeia